AGTHX
Price
$84.97
Change
+$0.98 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
WPASX
Price
$48.68
Change
+$0.88 (+1.84%)
Updated
Jul 31 closing price
Net Assets
461.2M
Interact to see
Advertisement

AGTHX vs WPASX

AGTHX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
AGTHX vs. WPASX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a StrongBuy and WPASX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 357B vs. WPASX (461M). AGTHX pays higher dividends than WPASX: AGTHX (0.26) vs WPASX (0.00). AGTHX was incepted earlier than WPASX: AGTHX (53 years) vs WPASX (12 years). WPASX (1.00) is less costly to investors than AGTHX (0.59). AGTHX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). AGTHX initial investment is less costly to investors than WPASX (4%) vs WPASX (4%). AGTHX has a lower initial minimum investment than WPASX: AGTHX (250) vs WPASX (2500). AGTHX annual gain was more profitable for investors over the last year : 1.64 vs. WPASX (-12.18). AGTHX return over 5 years is better than : 13.69 vs. WPASX (-19.18).
AGTHXWPASXAGTHX / WPASX
Total Expense Ratio0.591.0059%
Annual Report Gross Expense Ratio0.591.0059%
Fund Existence53 years12 years-
Gain YTD5.605-2.523-222%
Front Load6%4%135%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets357B461M77,440%
Annual Yield % from dividends0.260.00-
Returns for 1 year1.64-12.18-13%
Returns for 3 years36.13-1.02-3,550%
Returns for 5 years13.69-19.18-71%
Returns for 10 years100.5776.05132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEAM101.012.89
+2.95%
Atlassian Corp
SLQT0.750.02
+2.81%
SelectQuote
OGG2.390.01
+0.42%
Osisko Gold Group Inc
IMNN1.59-0.01
-0.62%
Imunon Inc
DNLI23.02-1.33
-5.46%
Denali Therapeutics